Systemic treatment of metastatic cancer with platelet factor 4
US5284827A · kind A · utility
16Cited by
2References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 19, 1990 |
| Grant date | Feb 8, 1994 |
| Priority date | — |
| Expiry date | Oct 19, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The subject invention concerns a novel treatment for cancer. Specifically, the invention concerns the systemic administration of recombinant Platelet Factor Four (rPF4) to inhibit tumor growth in a mammal having metastatic cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.